Characteristics of patients meeting the new definition of pulmonary hypertension (Nice 2018) in single Japanese PH center.

K. Yamamoto (Chiba, Japan), N. Tanabe (Chiba, Japan), R. Suda (Chiba, Japan), A. Naito (Chiba, Japan), A. Sekine (Chiba, Japan), R. Nishimura (Chiba, Japan), T. Jujo (Chiba, Japan), A. Shigeta (Chiba, Japan), S. Sakao (Chiba, Japan), K. Tatsumi (Chiba, Japan)

Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Session: Pulmonary arterial hypertension: recent advances from the bedside
Session type: Poster Discussion
Number: 5468
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Yamamoto (Chiba, Japan), N. Tanabe (Chiba, Japan), R. Suda (Chiba, Japan), A. Naito (Chiba, Japan), A. Sekine (Chiba, Japan), R. Nishimura (Chiba, Japan), T. Jujo (Chiba, Japan), A. Shigeta (Chiba, Japan), S. Sakao (Chiba, Japan), K. Tatsumi (Chiba, Japan). Characteristics of patients meeting the new definition of pulmonary hypertension (Nice 2018) in single Japanese PH center.. 5468

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
International guidelines for the chronic obstructive pulmonary disease (COPD) and the real therapeutic management of patients in Greece from pulmonologists and general practitioners (GPs)
Source: Eur Respir J 2002; 20: Suppl. 38, 398s
Year: 2002

What proportion of patients with Idiopathic Pulmonary Fibrosis fall outside UK prescribing criteria for anti-fibrotic treatment? A UK specialist centre review.
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019

Identifying chronic thromboembolic pulmonary hypertension (CTEPH) through French national hospital database (PMSI)
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018


A retrospective audit of chronic obstructive pulmonary disease (COPD) admissions to a university teaching hospital after publication of the British Thoracic Society (BTS) guidelines
Source: Eur Respir J 2001; 18: Suppl. 33, 26s
Year: 2001

Clinical characteristics of the pulmonary hypertension (PH) in a cardiologist service
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011


Use of prognostic indicators to identify patients with end stage COPD: A survey of South-West (SW) England clinicians
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013


Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014


AUDIPOC. National clinical audit on chronic obstructive pulmonary disease exacerbations (eCOPD) in Spain. Experience on mechanical ventilation in patients admitted for eCOPD. Pilot study in six autonomous regions
Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure
Year: 2009


Cardiovascular diseases (CVD), arterial hypertension (AH) and diabetes mellitus (DM) in a cohort of 609 COPD patients: Associations with the new GOLD classification 2011
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013


Comparison of characteristics of COPD patients with an established diagnosis, with those newly identified through case-finding – The Birmingham COPD cohort study
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014


Current epoprostenol use in patients with severe pulmonary hypertension (PH): Data from the French PH registry
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011

Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs
Source: Eur Respir Rev 2009; 18: 18-23
Year: 2009


Regional and practice-based variations in the diagnosis of chronic obstructive pulmonary disease (COPD) unexplained by deprivation, population demographics, and practice list size
Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care
Year: 2009


Chronic obstructive pulmonary disease (COPD) as co morbidity (CO) in different patient categories in a university hospital setting. A cross sectional study
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012


COPD classification according GOLD 2013 and Latin American Thoracic Association (ALAT) recommendations in PUMA study
Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing
Year: 2016

Longitudinal observation of idiopathic pulmonary fibrosis (IPF) patients cohort from one center in Poland.
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019

Socioeconomic position and use of drugs in chronic obstructive pulmonary disease (COPD): A population-based cohort study in Rome, Italy
Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Year: 2011


Clinical and epidemiological characteristics of chronic obstructive pulmonary disease (COPD) patients in Spain (VICE Study)
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006

Investigation of the prevalence of comorbidities in patients with COPD using the Italian college of general practitioners (SIMG) database
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009


Cost-effectiveness of an early supported discharge service (ESDS) for chronic obstructive pulmonary disease (COPD) in a university hospital serving a large rural population
Source: Annual Congress 2007 - Ethical and economic choices in respiratory care
Year: 2007